Jim Ratcliffe: Who is the man buying Man Utd stake?
One of the UK’s richest men, Sir Jim has built a multi-billion pound business by snapping up unloved assets.
One of the UK’s richest men, Sir Jim has built a multi-billion pound business by snapping up unloved assets.
Boeing CEO Dave Calhoun said the company acknowledges “our mistake,” after a door plug on a 737 Max 9 blew out in the middle of an Alaska Airlines flight, creating a gaping hole in the fuselage and prompting a grounding of that aircraft type by federal regulations. The Federal Aviation Administration grounded the 737 Max…
The executive chairman of Ford Motor Company broke his silence on the monthlong auto workers strike on Monday and said the work stoppage could “devastate local communities” if it continues. Bill Ford, the great-grandson of Henry Ford and the company’s chairman since 1999, also criticized the United Auto Workers union for recently shutting down the…
Over the course of nearly 100 years, Central Casting has come to dominate the TV and film industry as a major source of employment for thousands of actors across networks, studios, and streaming platforms. But current and former employees say that power has gone unchecked internally, creating what they say is a toxic workplace where…
Following rising domestic pressure to boycott Chinese-made goods, the Indian government on Monday ordered 59 Chinese apps to be blocked, including TikTok, WeChat, Shareit, and Clash of Kings. The Indian government framed the move as protecting personal information from what it called “malicious apps,” that “harm India’s sovereignty as well as the privacy of our…
Business & FinanceEconomy 14 December 2023, 4:50 am 1 minute Reuters was first to report that the U.S. Treasury Department’s Office of the Comptroller of the Currency (OCC) carried out its first climate risk assessment of more than two dozen banks in recent months, laying the groundwork for heightened scrutiny of Wall Street’s accounting for…
Updated Jan. 9, 2024 3:07 am ET GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows a string of pharmaceutical majors buying fast-growing biotechs to restock their pipelines. The British pharmaceutical giant said Tuesday that the deal to buy San Francisco and…